WollinaU. Pompholyx: a review of clinical features, differential diagnosis, and management. Am J Clin Dermatol, 2010; 11(5):305–314; doi: 10.2165/11533250-000000000-00000
2.
Calle SarmientoPM, Chango AzanzaJJ. Dyshidrotic eczema: a common cause of palmar dermatitis. Cureus, 2020; 12(10):e10839; doi: 10.7759/cureus.10839
3.
NandaS, NagraniN, MacQuhaeF, et al.A case of complete resolution of severe plantar dyshidrotic eczema with dupilumab. J Drugs Dermatol, 2019; 18(2):211–212.
4.
WaldmanRA, DeWaneME, SloanB, et al.Dupilumab for the treatment of dyshidrotic eczema in 15 consecutive patients. J Am Acad Dermatol, 2020; 82(5):1251–1252; doi: 10.1016/j.jaad.2019.12.053
5.
Guttman-YasskyE, TeixeiraHD, SimpsonEL, et al.Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (measure up 1 and measure up 2): results from two replicate double-blind, randomised controlled phase 3 trials. Lancet, 2021; 397(10290):2151–2168; doi: 10.1016/S0140-6736(21)00588-2
